Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications
about
A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.Design of the Park-in-Shape study: a phase II double blind randomized controlled trial evaluating the effects of exercise on motor and non-motor symptoms in Parkinson's disease.Effect and Potential Mechanism of Electroacupuncture Add-On Treatment in Patients with Parkinson's Disease.Clinical aspects and management of levodopa-induced dyskinesia.The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease: A Post Hoc Analysis.Non-Ergot Dopamine Agonists Do Not Increase the Risk of Heart Failure in Parkinson's Disease Patients: A Meta-Analysis of Randomized Controlled TrialsMotor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?Parkinson's Disease: From Pathogenesis to PharmacogenomicsComparison for Efficacy and Tolerability among Ten Drugs for Treatment of Parkinson's Disease: A Network Meta-Analysis.Passiflora cincinnata Extract Delays the Development of Motor Signs and Prevents Dopaminergic Loss in a Mice Model of Parkinson's Disease.Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's DiseaseEfficacy and safety of rotigotine in elderly patients with Parkinson's disease in comparison with the non-elderly: a post hoc analysis of randomized, double-blind, placebo-controlled trials.Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis.Motor Complications of Dopaminergic Medications in Parkinson's Disease.
P2860
Q30240991-FD140A06-A758-4DC0-8AFA-4CD15860C7FAQ35564412-70757C61-5252-414B-A15E-1D58B870EA00Q35999154-B5FF1D87-2471-49F6-A552-D5401A621862Q36022700-8EEFA3F1-7AF1-4A38-8069-1AB469FDB471Q36685653-A73E5B4F-779C-4EE4-9352-9A69735FD0F2Q36856977-03D48021-E50F-40D6-8BEB-6A6F2485FBF2Q37115650-CDF6AC47-8101-45F7-A8B8-CBE5214999DEQ37729129-F7A80932-2CC3-44B6-BD5D-D0BF07AFAD13Q37736512-8F6B3B94-51A8-4DBB-842E-EDA28D842690Q41395526-50555FD9-A813-447F-9317-755235CA862BQ41849974-A3578948-12D7-4384-8AAD-D6BD18918463Q47430695-36052902-8D67-46C7-978D-D7F52AFC7E90Q49926091-63F69FED-C0B1-4ACC-A8DE-2071632869A4Q55279095-470942BC-9A83-4BBC-97CD-EC29A9FE1276
P2860
Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Evaluation of the efficacy and ...... ients with motor complications
@ast
Evaluation of the efficacy and ...... ients with motor complications
@en
Evaluation of the efficacy and ...... ients with motor complications
@en-gb
Evaluation of the efficacy and ...... ients with motor complications
@nl
type
label
Evaluation of the efficacy and ...... ients with motor complications
@ast
Evaluation of the efficacy and ...... ients with motor complications
@en
Evaluation of the efficacy and ...... ients with motor complications
@en-gb
Evaluation of the efficacy and ...... ients with motor complications
@nl
prefLabel
Evaluation of the efficacy and ...... ients with motor complications
@ast
Evaluation of the efficacy and ...... ients with motor complications
@en
Evaluation of the efficacy and ...... ients with motor complications
@en-gb
Evaluation of the efficacy and ...... ients with motor complications
@nl
P2093
P2860
P50
P3181
P1476
Evaluation of the efficacy and ...... ients with motor complications
@en
P2093
Alex Furmston
Carl E Clarke
Kelly Handley
Richard Gray
van Hilten
P2860
P3181
P356
10.1002/14651858.CD007166.PUB2
P577
2010-07-07T00:00:00Z